JP2003527301A - エリスロマイシンa誘導体 - Google Patents

エリスロマイシンa誘導体

Info

Publication number
JP2003527301A
JP2003527301A JP2000517978A JP2000517978A JP2003527301A JP 2003527301 A JP2003527301 A JP 2003527301A JP 2000517978 A JP2000517978 A JP 2000517978A JP 2000517978 A JP2000517978 A JP 2000517978A JP 2003527301 A JP2003527301 A JP 2003527301A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
formula
mmol
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000517978A
Other languages
English (en)
Japanese (ja)
Inventor
俊文 朝賀
政人 樫村
亜紀子 松浦
智洋 杉本
哲也 谷川
孝明 石井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of JP2003527301A publication Critical patent/JP2003527301A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
JP2000517978A 1997-10-29 1998-10-28 エリスロマイシンa誘導体 Withdrawn JP2003527301A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29682297 1997-10-29
JP9-296822 1997-10-29
PCT/JP1998/004876 WO1999021869A1 (fr) 1997-10-29 1998-10-28 Derives de l'erythromycine a, 11,12-carbamate

Publications (1)

Publication Number Publication Date
JP2003527301A true JP2003527301A (ja) 2003-09-16

Family

ID=17838611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000517978A Withdrawn JP2003527301A (ja) 1997-10-29 1998-10-28 エリスロマイシンa誘導体

Country Status (4)

Country Link
JP (1) JP2003527301A (fr)
AU (1) AU9649598A (fr)
WO (1) WO1999021869A1 (fr)
ZA (1) ZA989835B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID30233A (id) 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
US6511962B1 (en) 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
AU2001278933B2 (en) * 2000-07-17 2006-05-25 Migenix Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
NZ526450A (en) * 2000-12-21 2005-04-29 Pliva Istrazivacki Inst D Macrolide antibiotics
AU2003234650A1 (en) * 2002-05-31 2003-12-19 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
GB0310981D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
AU2005317735B2 (en) 2004-12-21 2009-06-04 Pfizer Products Inc. Macrolides
CA2902624C (fr) 2013-02-28 2021-05-18 Takeda Pharmaceutical Company Limited Procede de production d'un compose de chlorure de sulfonyle
CN106432067B (zh) * 2016-09-18 2019-04-19 北京天弘天达医药科技有限公司 一种3-吡啶磺酰氯的绿色化学合成方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
WO1999021869A1 (fr) 1999-05-06
ZA989835B (en) 1999-05-05
AU9649598A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
KR100396168B1 (ko) 4″-치환된-9-데옥소-9a-아자-9a-호모에리트로마이신 A유도체
JP3334980B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
KR100369959B1 (ko) C-4″-치환된-마크롤리드 유도체
AU698939B2 (en) Benzoxazolyl- and benzothiazolyloxazolidinones
JP3441377B2 (ja) C−4”置換マクロライド抗生物質
RU2601550C2 (ru) Кетолидные соединения
US6191118B1 (en) Erythromycin A derivatives
JP2003527301A (ja) エリスロマイシンa誘導体
WO2007091393A1 (fr) COMPOSÉ 10a-AZALIDE
WO1993013116A1 (fr) Derive de 5-o-desosaminylerythronolide
JP2008519787A (ja) マクロロン化合物
JP2000500133A (ja) 三環式エリスロマイシン誘導体
KR20010013148A (ko) 세포 증식 억제제로서의 시아노구아니딘
JP2002502366A (ja) 3―デスクラジノース―2,3―無水エリスロマイシン誘導体
CN111936489A (zh) 新的白纹黄单胞菌毒素衍生物、其用途及合成
KR20010013158A (ko) 세포 증식 억제제로서의 시아노구아니딘
EP1607394B1 (fr) Derives de thalidomide hydrosoluble
JP2004514643A (ja) エリスロマイシンa誘導体
WO1998042720A1 (fr) Derives d'erythromycine a
JPWO2009139181A1 (ja) 4員環構造を有する10a−アザライド化合物
JP4248244B2 (ja) 12、13位変換新規16員環マクロライド誘導体
ES2208334T3 (es) Derivados cetolida de 6-0 carbamato.
JP2003501439A5 (fr)
EP0508725A1 (fr) Procédé de préparation de 8a-aza-8a-homoerythromycin iminoethers cyclique
US6831068B2 (en) Macrolide antibacterial compounds

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050324

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080918